1 Min Read
Aug 13 (Reuters) - Moberg Pharma AB : * Q2 - revenue msek 57.7 (44.9) * Q2 - EBITDA msek 6.9 (loss: 5.1) Link to press release: here
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.